top of page
Search

Regent’s Park Healthcare scores 100% across all lots and awarded a place onto £600 million NHS Supply Chain Angiography and Hybrid Theatre Framework

  • RPH News Editor
  • 2 days ago
  • 2 min read

ree

WILTSHIRE, United Kingdom, 8 December 2025: Regent's Park Healthcare is delighted to announce that it was today awarded a place on all four lots of NHS Supply Chain’s new national framework, “Angiography, Hybrid Theatres, Capital Equipment, Related Accessories and Services”, following a competitive open procurement process run by Supply Chain Coordination Limited.


In the evaluation, Regent’s Park Healthcare achieved a 100% score across all lots, a powerful independent endorsement of the quality, safety and responsiveness of its services. This reflects the organisation’s over twenty-year track record as a specialist provider of cardiac services and underpins its reputation as the UK’s leader in managed cardiology services to the NHS.


The framework establishes a compliant, value-driven route for NHS organisations across the UK to procure advanced angiography systems, managed services, mobile and relocatable catheter laboratories, and wearable radiation protection products.


Under the award, Regent’s Park Healthcare has been named as a supplier on:

  • Lot 1 – Angiography Equipment, Accessories & Services

  • Lot 2 – Managed Services (related to angiography equipment & accessories)

  • Lot 3 – Mobile and Relocatable Catheterisation Laboratories

  • Lot 4 – Wearable Radiation Protection Products


The framework has an initial two-year term from 8 December 2025 to 8 December 2027, with options to extend for a further two years to 8 December 2029. Across the four lots, the total indicative framework value is up to £600 million.


This appointment strengthens RPH’s position as a specialist provider of cardiac and vascular services, enabling NHS Trusts to call off:

  • High-end angiography and hybrid imaging equipment with associated accessories and clinical support (Lot 1)

  • Comprehensive managed service solutions, including equipment planning, lifecycle management, upgrades and training (Lot 2)

  • Fully equipped mobile and relocatable catheterisation laboratories to support elective recovery, waiting list initiatives and surge capacity (Lot 3)

  • A full range of wearable radiation protection products for staff working in interventional and imaging environments (Lot 4)


Dr Anil Ohri, Chief Executive Officer of Regent’s Park Healthcare, commented:

“We are delighted to have been selected on all four lots of this important national framework. Scoring 100% across every lot is a tremendous testament to the dedication of our teams and to the systems we have built over more than two decades across the field of cardiac services"

He added: "This recognition reinforces Regent’s Park Healthcare’s reputation as the UK’s leading provider of managed cardiology services to the NHS.

Being on this framework means Trusts can access not only our mobile and relocatable cath labs, but also end-to-end managed services, advanced imaging solutions and staff radiation protection – all through a vendor-neutral, compliant and efficient procurement route. We look forward to working with NHS Supply Chain and our Trust partners to help reduce waiting lists, modernise cath lab infrastructure and improve outcomes for patients with heart disease across the UK.”






 
 
 
bottom of page